India to Indonesia: Strip Export Trade Route

The India to Indonesia Strip corridor is one of India's established pharmaceutical export routes, with 54 shipments documented worth a combined $9.4M USD. The route is dominated by MANEESH PHARMACEUTICALS LIMITED , which alone accounts for roughly 67% of all export value, reflecting the consolidated nature of India's strip manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $174.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with strip's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 23.4%, placing it at rank #19 among India's top strip export destinations globally.

On the import side, key buyers of Indian strip in Indonesia include Dr Tiffany Tiara Pakasi , Sekretariat Ditjen Pencegahan , SEKRET ARIAT DITJEN PENCEGAHAN and 7 others. Dr Tiffany Tiara Pakasi is the single largest importer with 4 shipments valued at $3.5M USD.

India's strip exports to Indonesia are driven primarily by a handful of large-scale manufacturers. MANEESH PHARMACEUTICALS LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Indonesia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MANEESH PHARMACEUTICALS LIMITED , MANEESH PHARMACEUTICALS LIMITED, VARUN MEDIMPEX INC. — together account for 99% of total trade value on this route. The average shipment value of $174.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as 12 strips of 28 tablets each of rifampic and 12 strips of 28 tablets each of rifampic, suggesting that buyers in Indonesia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, Dr Tiffany Tiara Pakasi is the largest importer with 4 shipments worth $3.5M USD — representing 37% of all strip imports from India on this route. A total of 10 buyers are active on this corridor.